Overview

Misoprostol Dosing in BMI Greater Than 30

Status:
Not yet recruiting

Trial end date:
2023-04-01

Target enrollment:

Participant gender:

Summary

The investigators are performing a randomized controlled-trial investigating if 50mcg (compared to 25 mcg) of vaginal misoprostol reduces the time from induction start to delivery in obese women.

Phase:

Phase 4

Details

Lead Sponsor:

University of Texas at Austin

Treatments:

Misoprostol